ABSTRACT
Simultaneous bilateral primary breast carcinoma in the male is a rare occurrence. Prognostic factors determining the survival rate in male patients with breast cancer are the same as for those in female patients. Retraction and bloody discharge from the nipple, enlargement of axillary nodes, ulceration of the skin, and so forth indicate a poor prognosis. Early detection of cancer using the best available modality, therefore, is of great importance in improving the survival of these patients.
Subject(s)
Breast Neoplasms/diagnostic imaging , Gynecomastia/diagnostic imaging , Mammography , Adolescent , Adult , Aged , Breast Diseases/diagnostic imaging , Child , Gynecomastia/etiology , Gynecomastia/pathology , Humans , Male , Middle AgedABSTRACT
Pedal lymphography was performed without the use of vital dyes in 510 patients. Lymphatic vessels were still readily identifiable by this method, due to their transparency, clarity, elasticity, distensibility, and characteristic branching pattern. Procedure time was shortened by 10-15 minutes without compromising the high success rate.
Subject(s)
Coloring Agents , Lymphography/methods , Adolescent , Adult , Aged , Child , Coloring Agents/adverse effects , Contrast Media/adverse effects , Humans , Middle Aged , Time FactorsABSTRACT
An unusual case of gallstones within the duodenum, secondary to obstruction by an intraluminal diverticulum, is reported. The gallbladder appeared normal an oral cholecystogram, excluding internal biliary fistula as the source of duodenal gallstones.
Subject(s)
Cholelithiasis/complications , Diverticulum/complications , Duodenal Diseases/complications , Duodenal Obstruction/complications , Duodenum , Adult , Cholelithiasis/diagnostic imaging , Dilatation, Pathologic , Diverticulum/diagnostic imaging , Duodenal Diseases/diagnostic imaging , Duodenal Obstruction/diagnostic imaging , Duodenum/diagnostic imaging , Female , Humans , RadiographyABSTRACT
This study was undertaken to determine the relationship between thyroid supplements and breast cancer. The incidence of breast cancer among the patients who received thyroid supplements was 12.13%, while in the control group it was 6.2%. The incidence rate of breast cancer was 10%, 9.42%, and 19.48% among patients who received thyroid supplements for one to five, 5 to 15, and for more than 15 years, respectively. The incidence of breast cancer among nulliparous women who received thyroid supplements was 33%, while in the nulliparous women without thyroid supplements the incidence was only 9.25%. Even in a specific age group, the incidence rate of breast cancer was higher among patients receiving thyroid supplements, when compared to the control patients in the same age group.
